Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #311718 on Elite Pharmaceuticals Inc (ELTP)
Chasing
03/12/19 2:22 PM
#311755 RE: namtae #311718
we did launch 17 products in calendar year 2018 as forecasted. We are reaffirming that they will contribute approximately $75 million of net sales in fiscal 2019 at a gross margin of at least 35%. Because in the first half of fiscal 2019, those same products generated approximately $40 million of net sales with a gross margin of about 37%. Also, we previously said our plan is to continue that pace of launches for the foreseeable future. Our launch "parade" continues and includes approximately 10 planned launches in the next – in the first half of this calendar year and more launches thereafter.